Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Abcellera Biologics Inc reports results for the quarter ended in March - Earnings Summary

* Abcellera Biologics Inc  ABCL.OQ  reported a quarterly
adjusted
loss of 14 cents​​ per share for the quarter ended in March,
identical to the same quarter last year.  The mean expectation
of nine analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -25 cents
to -13 cents per share.
    * Revenue fell 18.4% to $9.95 million from a year ago;
analysts
expected $10.84 million. 
    * Abcellera Biologics Inc's reported EPS for the quarter was
a
loss of 14 cents​.
    * The company reported a quarterly loss of $40.61 million.
    * Abcellera Biologics Inc shares had fallen by 10.8% this
quarter and lost 29.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 33%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Abcellera
Biologics Inc is $14.50 
This summary was machine generated from LSEG data May 8 at 07:40
a.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.17          -0.14          Beat
 Dec. 31 2023      -0.13          -0.17          Missed
 Sep. 30 2023      -0.13          -0.10          Beat
 Jun. 30 2023      -0.13          -0.11          Beat

Recent news on AbCellera Biologics

See all news